Parison Amy 4

What Happened
Amy Parison, Chief Financial Officer of Editas Medicine (EDIT), sold 464 shares on June 3, 2026 in a transaction totaling about $1,253. The reported weighted-average price was $2.70 per share. This was a sale (not a purchase) and appears to be a routine disposition to satisfy tax obligations, not a discretionary trade.

Key Details

• Transaction date: June 3, 2026; Form 4 filed June 5, 2026. No indication in the provided data that the filing was late.
• Price: weighted average $2.70; executed in multiple trades at $2.7010–$2.7049 (report reflects weighted average).
• Shares disposed: 464; proceeds ≈ $1,253.
• Footnote: Sale was effected under a durable automatic sales instruction plan adopted July 7, 2022, to cover tax withholding for restricted stock units that vested on June 2, 2026; sale was not a discretionary trade by the reporting person. Reporting person offers to provide full trade-by-trade details on request.
• Shares owned after transaction: not disclosed in the provided filing.

Context
This sale was executed to meet tax withholding on RSU vesting and was automated (non-discretionary), a common reason for small insider sales that does not necessarily indicate a change in insider sentiment. For retail investors, purchases by insiders typically carry more signaling weight than routine tax-withholding sales.